123 related articles for article (PubMed ID: 37974528)
1. Prognostic value of preoperative De Ritis ratio on oncological outcomes in patients with muscle-invasive bladder cancer.
Sretenovic M; Lisicic N; Bulat P; Radisavcevic D; Bumbasirevic U; Cegar B; Milojevic IG; Grujicic SS; Milojevic B
J Surg Oncol; 2024 Mar; 129(3):641-648. PubMed ID: 37974528
[TBL] [Abstract][Full Text] [Related]
2. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
4. Association Between Preoperative De Ritis (AST/ALT) Ratio and Oncological Outcomes Following Radical Cystectomy in Patients With Urothelial Bladder Cancer.
Ghahari M; Salari A; Ghafoori Yazdi M; Nowroozi A; Fotovat A; Momeni SA; Nowroozi MR; Amini E
Clin Genitourin Cancer; 2022 Apr; 20(2):e89-e93. PubMed ID: 34866017
[TBL] [Abstract][Full Text] [Related]
5. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
6. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.
Mori K; Janisch F; Mostafaei H; Kimura S; Lysenko I; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Shariat SF
Urol Oncol; 2020 Jun; 38(6):601.e17-601.e24. PubMed ID: 32127252
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic impact of preoperative thrombocytosis in muscle invasive bladder cancer: Any role in clinical practice?
Sretenovic M; Bojanic N; Grozdic Milojevic I; Bumbasirevic U; Radisavcevic D; Bulat P; Sipetic Grujicic S; Milojevic B
J Clin Ultrasound; 2023; 51(9):1607-1614. PubMed ID: 37882791
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy.
Liu J; Dai Y; Zhou F; Long Z; Li Y; Liu B; Xie D; Tang J; Tan J; Yao K; Zhang Y; Tang Y; He L
Urol Oncol; 2016 Nov; 34(11):484.e1-484.e8. PubMed ID: 27341738
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
[TBL] [Abstract][Full Text] [Related]
12. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
13. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
14. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis.
Hu X; Yang WX; Wang Y; Shao YX; Xiong SC; Li X
Cancer Cell Int; 2020; 20():39. PubMed ID: 32042266
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
[TBL] [Abstract][Full Text] [Related]
17. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; König F; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
BJU Int; 2022 Feb; 129(2):182-193. PubMed ID: 33650265
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; D Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Chlosta P; Babjuk M; Deuker M; Moschini M; Shariat SF; Pradere B
Urol Oncol; 2021 Apr; 39(4):235.e5-235.e14. PubMed ID: 33189530
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
[TBL] [Abstract][Full Text] [Related]
20. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
